Preclinical Comparison of the 64Cu- and 68Ga-Labeled GRPR-Targeted Compounds RM2 and AMTG, as Well as First-in-Humans [68Ga]Ga-AMTG PET/CT.
J Nucl Med
; 64(10): 1654-1659, 2023 10.
Article
in En
| MEDLINE
| ID: mdl-37934025
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Receptors, Bombesin
/
Neoplasms
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
J Nucl Med
Year:
2023
Document type:
Article
Affiliation country:
Alemania
Country of publication:
Estados Unidos